Evidence map›Paper›PMID 15240502›Full record

ArticleBiophysical journal2004

Controlled pseudopod extension of human neutrophils stimulated with different chemoattractants.

Doncho V Zhelev, Abdullatif M Alteraifi, David Chodniewicz

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 79 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Combinative in vitro studies and computational model to predict 3D cell migration response to drug insult.Integrative biology : quantitative biosciences from nano to macro · 2014
    Article
  16. Probabilistic Voxel-Fe model for single cell motility in 3D.In silico cell and tissue science · 2014
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Doncho V ZhelevDepartment of Mechanical Engineering and Materials Science, Duke University, Durham, North Carolina 27708-0300, USA. dvzh@duke.edu
Abdullatif M Alteraifi
David Chodniewicz
Duke University · USUnited Arab Emirates University · AE

Funding

University Training Program in Biomolecular & Tissue EngineeringT32GM008555 · NIGMS · DUKE UNIVERSITY · PI GERSBACH, CHARLES A. · 1994 to 2021
$8.1M
SIGNALING IN NEUTROPHIL MOTILITYR29HL057629 · NHLBI · DUKE UNIVERSITY · PI JELEV, DONTCHO V · 1997 to 2001
$186k
NCRR NIH HHS M01-RR-30NHLBI NIH HHS HL57629NIGMS NIH HHS GM08555NIGMS NIH HHS T32 GM008555
6 · The paper itself

Abstract

The formation of pseudopods and lamellae after ligation of chemoattractant sensitive G-protein coupled receptors (GPCRs) is essential for chemotaxis. Here, pseudopod extension was stimulated with chemoattractant delivered from a micropipet. The chemoattractant diffusion and convection mass transport were considered, and it is shown that when the delivery of chemoattractant was limited by diffusion there was a strong chemoattractant gradient along the cell surface. The diffusion-limited delivery of chemoattractant from a micropipet allowed for maintaining an almost constant chemoattractant concentration at the leading edge of single pseudopods during their growth. In these conditions, the rate of pseudopod extension was dependent on the concentration of chemoattractant in the pipet delivering chemoattractant. The pseudopod extension induced using micropipets was oscillatory even in the presence of a constant delivery of chemoattractant. This oscillatory pseudopod extension was controlled by activated RhoA and its downstream effector kinase ROCK and was abolished after the inhibition of RhoA activation with Clostridium botulinium C3 exoenzyme (C3) or the blocking of ROCK activation with Y-27632. The ability of the micropipet assay to establish a well-defined chemoattractant distribution around the activated cell over a wide range of molecular weights of the used chemoattractants allowed for comparison of the effect of chemoattractant stimulation on the dynamics of pseudopod growth. Pseudopod growth was stimulated using N-formylated peptide (N-formyl-methionyl-leucyl-phenylalanine (fMLP)), platelet activating factor (PAF), leukotriene B4 (LTB(4)), C5a anaphylotoxin (C5a), and interleukin-8 (IL-8), which represent the typical ligands for G-protein coupled chemotactic receptors. The dependence of the rate of pseudopod extension on the concentration of these chemoattractants and their equimolar mixture was measured and shown to be similar for all chemoattractants. The inhibition of the activity of phosphoinositide-3 kinase (PI3K) with wortmannin showed that 72%-80% of the rate of pseudopod extension induced with N-formyl-methionyl-leucyl-phenylalanine, platelet activating factor, and leukotriene B4 was phosphoinositide-3 kinase-dependent, in contrast to 55% of the rate of pseudopod extension induced with interleukin-8. The dependence of the rate of pseudopod extension on the concentration of individual chemoattractants and their equimolar mixture suggests that there is a common rate-limiting mechanism for the polymerization of cytoskeletal F-actin in the pseudopod region induced by G-protein coupled chemoattractant receptors.

Indexed as

ActinsADP Ribose TransferasesAmidesAnaphylatoxinsAndrostadienesBotulinum ToxinsChemotactic FactorsChemotaxisHumansInterleukin-8Intracellular Signaling Peptides and ProteinsLeukotriene B4NeutrophilsN-Formylmethionine Leucyl-PhenylalaninePhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsActinsADP Ribose TransferasesAmidesAnaphylatoxinsAndrostadienesBotulinum ToxinsChemotactic Factorsexoenzyme C3, Clostridium botulinumInterleukin-8Intracellular Signaling Peptides and ProteinsLeukotriene B4N-Formylmethionine Leucyl-PhenylalaninePhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPlatelet Activating FactorProtein Kinase InhibitorsProtein Serine-Threonine KinasesPyridinesrhoA GTP-Binding Proteinrho-Associated KinasesWortmanninY 27632

Identifiers

PMID15240502
PMCPMC1304392
OpenAlexW2167903382

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.